Adding Tislelizumab to Chemo Slows Advanced Nasopharyngeal Cancer
Progression-free survival prolonged with tislelizumab + chemotherapy versus chemotherapy alone in recurrent/metastatic NPC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.